Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collier, A.
Right arrow Articles by Clarke, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collier, A.
Right arrow Articles by Clarke, B. F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 10, Issue 6 712-715, Copyright © 1987 by American Diabetes Association


ARTICLES

Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department

A Collier, DJ Steedman, AW Patrick, GR Nimmo, DM Matthews, CC MacIntyre, K Little and BF Clarke
Diabetic and Dietetic Department, Royal Infirmary, Edinburgh, United Kingdom.

Hypoglycemia is a serious problem in insulin-treated diabetic patients. In this study the efficacy of intravenous glucagon (1 mg) was compared with that of intravenous dextrose (25 g) in the treatment of hypoglycemia in insulin-treated patients attending an accident and emergency department. In addition, the prevailing glycemic control of these patients was compared with patients routinely attending a diabetic outpatient clinic. Both intravenous glucagon and dextrose were effective in the treatment of hypoglycemic coma. There was a difference in the glycemic profile after intravenous glucagon compared with intravenous dextrose, and recovery of a normal level of consciousness after glucagon was slower than after dextrose (6.5 vs. 4.0 min, respectively; P less than .001), although the average duration of hypoglycemic coma was 1.4 h. The glucagon- and dextrose-treated groups had significantly lower HbA1 than comparable patients routinely attending the clinic (9.5 +/- 0.8 vs. 12.0 +/- 3.8%, respectively; P less than .001). In view of the ease of administration and the small risk of vascular and extravascular complications, intravenous glucagon appears to be a useful alternative to intravenous dextrose in the treatment of severe hypoglycemia.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Emerg. Med. J.Home page
C Moore and M Woollard
Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomised controlled trial
Emerg. Med. J., July 1, 2005; 22(7): 512 - 515.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
R. Boyd and B. Foëx
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Closure of pretibial lacerations.
Emerg. Med. J., July 1, 2000; 17(4): 287 - 288.
[Full Text]


Home page
The Diabetes EducatorHome page
C. E. Havlin and P. E. Cryer
Hypoglycemia: The Limiting Factor in the Management of Insulin-Dependent Diabetes Mellitus
The Diabetes Educator, January 1, 1988; 14(5): 407 - 411.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1987 by the American Diabetes Association.